Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension Moderated by COVID-19 Diagnosis Among US Commercial Enrollees
Hypertension was associated with higher medical costs, healthcare utilization, and productivity losses, exacerbated by COVID-19.
Authors
- Jun Soo Lee (ORCID: https://orcid.org/0000-0003-3432-6466)
- Bruce Donald (ORCID: https://orcid.org/0000-0003-2706-3821)
- Ashutosh Kumar (ORCID: https://orcid.org/0000-0001-6680-7235)
- Yu Wang (ORCID: https://orcid.org/0000-0002-1481-5329)
- Feijun Luo (ORCID: https://orcid.org/0000-0002-7132-2854)
- Joohyun Park (ORCID: https://orcid.org/0000-0003-0599-780X)
- Yidan Zhang (ORCID: https://orcid.org/0000-0002-7589-530X)
- Kakoli Roy
Institutions
- American Heart Association (US)
- Centers for Disease Control and Prevention (US)
- Georgia Department of Natural Resources (US)
- Centers for Disease Control and Prevention (UG)
- National Center for Chronic Disease Prevention and Health Promotion (US)
- The Centers (US)
- Centers for Disease Control and Prevention (KE)
- Center for Prevention Services (US)
- University of West Georgia (US)
Publication Details
- Journal
- American Journal of Hypertension
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1093/ajh/hpaf081
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00